KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly Post author:Sam Post published:January 4, 2018 Post category:BioPharma The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace You Might Also Like NantHealth's Expands His Empire With Plans to Open a World-Class Cancer Center This Summer June 8, 2017 Can-Fite BioPharma Reports First Quarter 2017 Financial Results & Provides Clinical Update May 29, 2017 FDA Calls Bay Area Zogenix's Dravet Syndrome Drug a Breakthrough February 5, 2018
NantHealth's Expands His Empire With Plans to Open a World-Class Cancer Center This Summer June 8, 2017
Can-Fite BioPharma Reports First Quarter 2017 Financial Results & Provides Clinical Update May 29, 2017
